Global Killer-cell immunoglobulin-like receptors (KIRs) Supply, Demand and Key Producers, 2026-2032
The global Killer-cell immunoglobulin-like receptors (KIRs) market size is expected to reach $ 157 million by 2032, rising at a market growth of 8.4% CAGR during the forecast period (2026-2032).
Killer-cell immunoglobulin-like receptors (KIRs) are a family of transmembrane glycoprotein receptors mainly expressed on natural killer cells and subsets of T cells, and the term also refers to the related commercial products and services built around KIR proteins, KIR genes, ligand recognition, and functional immune analysis. They are not visible stand-alone devices, but molecular receptors located on the cell membrane, typically composed of extracellular immunoglobulin-like domains, a transmembrane region, and a cytoplasmic tail. Structurally, KIRs can contain two or three extracellular immunoglobulin-like domains, while functionally they include inhibitory and activating receptor types. Commercial products include genotyping kits, sequencing and testing services, flow cytometry antibodies, conjugated antibodies, recombinant proteins, plasmids, cell models, and reference antibodies for drug discovery. Their mechanism is based on recognizing human leukocyte antigen-related ligands and regulating natural killer cell cytotoxicity, immune tolerance, and immune surveillance. Major use scenarios include transplant immunogenetics, natural killer cell research, oncology immunology, immune phenotyping, therapeutic antibody discovery, cell therapy development, and reproductive immunology research.
Market growth opportunities are mainly supported by three demand streams. First, transplant immunogenetics and cell therapy are increasing the need to understand donor-recipient immune background, which supports demand for genotyping, receptor-ligand analysis, and immune risk assessment. Second, the rising importance of natural killer cells in oncology, infectious disease, and autoimmune research is expanding demand for flow cytometry antibodies, recombinant proteins, and functional validation materials. Third, more specific receptor targets are moving part of the market closer to translational development, especially in therapeutic antibody programs, immune monitoring, and potential companion testing workflows.
The main market challenges are clinical evidence, standardization, and commercial scale. These products are used mostly by specialized laboratories, transplant centers, academic institutes, and drug developers, so the customer base is much narrower than that of routine clinical diagnostics. Complex polymorphism, haplotype variation, gene copy number differences, and platform-specific interpretation create technical barriers in quality control and reporting. The value of routine KIR-based decision-making still requires stronger prospective evidence, so near-term market development should be assessed as steady professional adoption rather than mass-market expansion.
Downstream demand is expected to shift from single-product purchasing toward integrated solutions. Transplant-related users will increasingly combine genotyping, ligand matching, and long-term outcome data. Oncology immunology users will focus more on receptor expression, immune-cell functional status, and treatment response monitoring. Drug developers will require higher target specificity, antibody affinity validation, cytotoxicity mechanism studies, and clinical sample-based evidence. Faster-growing product categories are likely to include high-throughput typing, conjugated antibody panels, recombinant proteins, reference antibodies, and testing services designed for clinical research.
This report studies the global Killer-cell immunoglobulin-like receptors (KIRs) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Killer-cell immunoglobulin-like receptors (KIRs), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Killer-cell immunoglobulin-like receptors (KIRs) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Killer-cell immunoglobulin-like receptors (KIRs) total market, 2021-2032, (USD Million)
Global Killer-cell immunoglobulin-like receptors (KIRs) total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Killer-cell immunoglobulin-like receptors (KIRs) total market, key domestic companies, and share, (USD Million)
Global Killer-cell immunoglobulin-like receptors (KIRs) revenue by player, revenue and market share 2021-2026, (USD Million)
Global Killer-cell immunoglobulin-like receptors (KIRs) total market by Type, CAGR, 2021-2032, (USD Million)
Global Killer-cell immunoglobulin-like receptors (KIRs) total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Killer-cell immunoglobulin-like receptors (KIRs) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Becton Dickinson, Beckman Coulter Life Sciences, Bio-Rad, Revvity, Bio-Techne, Miltenyi Biotec, Merck, Abcam, Werfen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Killer-cell immunoglobulin-like receptors (KIRs) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Killer-cell immunoglobulin-like receptors (KIRs) Market, By Region:
1. How big is the global Killer-cell immunoglobulin-like receptors (KIRs) market?
2. What is the demand of the global Killer-cell immunoglobulin-like receptors (KIRs) market?
3. What is the year over year growth of the global Killer-cell immunoglobulin-like receptors (KIRs) market?
4. What is the total value of the global Killer-cell immunoglobulin-like receptors (KIRs) market?
5. Who are the Major Players in the global Killer-cell immunoglobulin-like receptors (KIRs) market?
6. What are the growth factors driving the market demand?
Killer-cell immunoglobulin-like receptors (KIRs) are a family of transmembrane glycoprotein receptors mainly expressed on natural killer cells and subsets of T cells, and the term also refers to the related commercial products and services built around KIR proteins, KIR genes, ligand recognition, and functional immune analysis. They are not visible stand-alone devices, but molecular receptors located on the cell membrane, typically composed of extracellular immunoglobulin-like domains, a transmembrane region, and a cytoplasmic tail. Structurally, KIRs can contain two or three extracellular immunoglobulin-like domains, while functionally they include inhibitory and activating receptor types. Commercial products include genotyping kits, sequencing and testing services, flow cytometry antibodies, conjugated antibodies, recombinant proteins, plasmids, cell models, and reference antibodies for drug discovery. Their mechanism is based on recognizing human leukocyte antigen-related ligands and regulating natural killer cell cytotoxicity, immune tolerance, and immune surveillance. Major use scenarios include transplant immunogenetics, natural killer cell research, oncology immunology, immune phenotyping, therapeutic antibody discovery, cell therapy development, and reproductive immunology research.
Market growth opportunities are mainly supported by three demand streams. First, transplant immunogenetics and cell therapy are increasing the need to understand donor-recipient immune background, which supports demand for genotyping, receptor-ligand analysis, and immune risk assessment. Second, the rising importance of natural killer cells in oncology, infectious disease, and autoimmune research is expanding demand for flow cytometry antibodies, recombinant proteins, and functional validation materials. Third, more specific receptor targets are moving part of the market closer to translational development, especially in therapeutic antibody programs, immune monitoring, and potential companion testing workflows.
The main market challenges are clinical evidence, standardization, and commercial scale. These products are used mostly by specialized laboratories, transplant centers, academic institutes, and drug developers, so the customer base is much narrower than that of routine clinical diagnostics. Complex polymorphism, haplotype variation, gene copy number differences, and platform-specific interpretation create technical barriers in quality control and reporting. The value of routine KIR-based decision-making still requires stronger prospective evidence, so near-term market development should be assessed as steady professional adoption rather than mass-market expansion.
Downstream demand is expected to shift from single-product purchasing toward integrated solutions. Transplant-related users will increasingly combine genotyping, ligand matching, and long-term outcome data. Oncology immunology users will focus more on receptor expression, immune-cell functional status, and treatment response monitoring. Drug developers will require higher target specificity, antibody affinity validation, cytotoxicity mechanism studies, and clinical sample-based evidence. Faster-growing product categories are likely to include high-throughput typing, conjugated antibody panels, recombinant proteins, reference antibodies, and testing services designed for clinical research.
This report studies the global Killer-cell immunoglobulin-like receptors (KIRs) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Killer-cell immunoglobulin-like receptors (KIRs), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Killer-cell immunoglobulin-like receptors (KIRs) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Killer-cell immunoglobulin-like receptors (KIRs) total market, 2021-2032, (USD Million)
Global Killer-cell immunoglobulin-like receptors (KIRs) total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Killer-cell immunoglobulin-like receptors (KIRs) total market, key domestic companies, and share, (USD Million)
Global Killer-cell immunoglobulin-like receptors (KIRs) revenue by player, revenue and market share 2021-2026, (USD Million)
Global Killer-cell immunoglobulin-like receptors (KIRs) total market by Type, CAGR, 2021-2032, (USD Million)
Global Killer-cell immunoglobulin-like receptors (KIRs) total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Killer-cell immunoglobulin-like receptors (KIRs) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Becton Dickinson, Beckman Coulter Life Sciences, Bio-Rad, Revvity, Bio-Techne, Miltenyi Biotec, Merck, Abcam, Werfen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Killer-cell immunoglobulin-like receptors (KIRs) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Killer-cell immunoglobulin-like receptors (KIRs) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- KIR Genotyping Products and Services
- KIR/CD158 Antibodies and Flow Cytometry Reagents
- Recombinant KIR Proteins and Related Research Reagents
- 2D KIR Products
- 3D KIR Products
- Pan-KIR or Mixed KIR Panel Products
- Inhibitory KIR-related Products
- Activating KIR-related Products
- Mixed KIR Panel Products
- Medical Science
- Experiment
- Other
- Thermo Fisher Scientific
- Becton Dickinson
- Beckman Coulter Life Sciences
- Bio-Rad
- Revvity
- Bio-Techne
- Miltenyi Biotec
- Merck
- Abcam
- Werfen
- CareDx
- GenDx
- HistoGenetics
- DKMS Life Science Lab
- Scisco Genetics
- Labcorp
- GeneTex
- Proteintech
- Cell Signaling Technology
- OriGene
- MyBioSource
- Aviva Systems Biology
- NSJ Bioreagents
- Boster Bio
- KACTUS
- ProteoGenix
- Biorbyt
- Abbexa
- St John?s Laboratory
- Innate Pharma
- ACROBiosystems
- Sino Biological
- GenScript
- CUSABIO
- Solarbio
- WeHelp
- CapitalBio
- Genomeditech
- Abnova
1. How big is the global Killer-cell immunoglobulin-like receptors (KIRs) market?
2. What is the demand of the global Killer-cell immunoglobulin-like receptors (KIRs) market?
3. What is the year over year growth of the global Killer-cell immunoglobulin-like receptors (KIRs) market?
4. What is the total value of the global Killer-cell immunoglobulin-like receptors (KIRs) market?
5. Who are the Major Players in the global Killer-cell immunoglobulin-like receptors (KIRs) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Killer-cell immunoglobulin-like receptors (KIRs) Introduction
1.2 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Killer-cell immunoglobulin-like receptors (KIRs) Total Market by Region (by Headquarter Location)
1.3.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032)
1.3.3 China Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032)
1.3.4 Europe Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032)
1.3.5 Japan Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032)
1.3.6 South Korea Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032)
1.3.7 ASEAN Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032)
1.3.8 India Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
2.2 World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region
2.2.1 World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2021-2026)
2.2.2 World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Forecast by Region (2027-2032)
2.3 United States Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
2.4 China Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
2.5 Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
2.6 Japan Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
2.7 South Korea Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
2.8 ASEAN Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
2.9 India Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
3 WORLD KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS (KIRS) COMPANIES COMPETITIVE ANALYSIS
3.1 World Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Killer-cell immunoglobulin-like receptors (KIRs) in 2025
3.2.3 Global Concentration Ratios (CR8) for Killer-cell immunoglobulin-like receptors (KIRs) in 2025
3.3 Killer-cell immunoglobulin-like receptors (KIRs) Company Evaluation Quadrant
3.4 Killer-cell immunoglobulin-like receptors (KIRs) Market: Overall Company Footprint Analysis
3.4.1 Killer-cell immunoglobulin-like receptors (KIRs) Market: Region Footprint
3.4.2 Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Type Footprint
3.4.3 Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Killer-cell immunoglobulin-like receptors (KIRs) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Killer-cell immunoglobulin-like receptors (KIRs) Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Comparison
4.2.1 United States VS China: Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Killer-cell immunoglobulin-like receptors (KIRs) Companies and Market Share, 2021-2026
4.3.1 United States Based Killer-cell immunoglobulin-like receptors (KIRs) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue, (2021-2026)
4.4 China Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue and Market Share, 2021-2026
4.4.1 China Based Killer-cell immunoglobulin-like receptors (KIRs) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue, (2021-2026)
4.5 Rest of World Based Killer-cell immunoglobulin-like receptors (KIRs) Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Killer-cell immunoglobulin-like receptors (KIRs) Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 KIR Genotyping Products and Services
5.2.2 KIR/CD158 Antibodies and Flow Cytometry Reagents
5.2.3 Recombinant KIR Proteins and Related Research Reagents
5.3 Market Segment by Type
5.3.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026)
5.3.2 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2027-2032)
5.3.3 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TARGET STRUCTURE
6.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Overview by Target Structure: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Target Structure
6.2.1 2D KIR Products
6.2.2 3D KIR Products
6.2.3 Pan-KIR or Mixed KIR Panel Products
6.3 Market Segment by Target Structure
6.3.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure (2021-2026)
6.3.2 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure (2027-2032)
6.3.3 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Target Structure (2027-2032)
7 MARKET ANALYSIS BY FUNCTION
7.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Overview by Function: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Function
7.2.1 Inhibitory KIR-related Products
7.2.2 Activating KIR-related Products
7.2.3 Mixed KIR Panel Products
7.3 Market Segment by Function
7.3.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function (2021-2026)
7.3.2 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function (2027-2032)
7.3.3 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Function (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Medical Science
8.2.2 Experiment
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026)
8.3.2 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2027-2032)
8.3.3 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Details
9.1.2 Thermo Fisher Scientific Major Business
9.1.3 Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.1.4 Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 Becton Dickinson
9.2.1 Becton Dickinson Details
9.2.2 Becton Dickinson Major Business
9.2.3 Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.2.4 Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Becton Dickinson Recent Developments/Updates
9.2.6 Becton Dickinson Competitive Strengths & Weaknesses
9.3 Beckman Coulter Life Sciences
9.3.1 Beckman Coulter Life Sciences Details
9.3.2 Beckman Coulter Life Sciences Major Business
9.3.3 Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.3.4 Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Beckman Coulter Life Sciences Recent Developments/Updates
9.3.6 Beckman Coulter Life Sciences Competitive Strengths & Weaknesses
9.4 Bio-Rad
9.4.1 Bio-Rad Details
9.4.2 Bio-Rad Major Business
9.4.3 Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.4.4 Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Bio-Rad Recent Developments/Updates
9.4.6 Bio-Rad Competitive Strengths & Weaknesses
9.5 Revvity
9.5.1 Revvity Details
9.5.2 Revvity Major Business
9.5.3 Revvity Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.5.4 Revvity Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Revvity Recent Developments/Updates
9.5.6 Revvity Competitive Strengths & Weaknesses
9.6 Bio-Techne
9.6.1 Bio-Techne Details
9.6.2 Bio-Techne Major Business
9.6.3 Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.6.4 Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Bio-Techne Recent Developments/Updates
9.6.6 Bio-Techne Competitive Strengths & Weaknesses
9.7 Miltenyi Biotec
9.7.1 Miltenyi Biotec Details
9.7.2 Miltenyi Biotec Major Business
9.7.3 Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.7.4 Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Miltenyi Biotec Recent Developments/Updates
9.7.6 Miltenyi Biotec Competitive Strengths & Weaknesses
9.8 Merck
9.8.1 Merck Details
9.8.2 Merck Major Business
9.8.3 Merck Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.8.4 Merck Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Merck Recent Developments/Updates
9.8.6 Merck Competitive Strengths & Weaknesses
9.9 Abcam
9.9.1 Abcam Details
9.9.2 Abcam Major Business
9.9.3 Abcam Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.9.4 Abcam Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Abcam Recent Developments/Updates
9.9.6 Abcam Competitive Strengths & Weaknesses
9.10 Werfen
9.10.1 Werfen Details
9.10.2 Werfen Major Business
9.10.3 Werfen Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.10.4 Werfen Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Werfen Recent Developments/Updates
9.10.6 Werfen Competitive Strengths & Weaknesses
9.11 CareDx
9.11.1 CareDx Details
9.11.2 CareDx Major Business
9.11.3 CareDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.11.4 CareDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 CareDx Recent Developments/Updates
9.11.6 CareDx Competitive Strengths & Weaknesses
9.12 GenDx
9.12.1 GenDx Details
9.12.2 GenDx Major Business
9.12.3 GenDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.12.4 GenDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 GenDx Recent Developments/Updates
9.12.6 GenDx Competitive Strengths & Weaknesses
9.13 HistoGenetics
9.13.1 HistoGenetics Details
9.13.2 HistoGenetics Major Business
9.13.3 HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.13.4 HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 HistoGenetics Recent Developments/Updates
9.13.6 HistoGenetics Competitive Strengths & Weaknesses
9.14 DKMS Life Science Lab
9.14.1 DKMS Life Science Lab Details
9.14.2 DKMS Life Science Lab Major Business
9.14.3 DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.14.4 DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 DKMS Life Science Lab Recent Developments/Updates
9.14.6 DKMS Life Science Lab Competitive Strengths & Weaknesses
9.15 Scisco Genetics
9.15.1 Scisco Genetics Details
9.15.2 Scisco Genetics Major Business
9.15.3 Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.15.4 Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Scisco Genetics Recent Developments/Updates
9.15.6 Scisco Genetics Competitive Strengths & Weaknesses
9.16 Labcorp
9.16.1 Labcorp Details
9.16.2 Labcorp Major Business
9.16.3 Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.16.4 Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Labcorp Recent Developments/Updates
9.16.6 Labcorp Competitive Strengths & Weaknesses
9.17 GeneTex
9.17.1 GeneTex Details
9.17.2 GeneTex Major Business
9.17.3 GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.17.4 GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 GeneTex Recent Developments/Updates
9.17.6 GeneTex Competitive Strengths & Weaknesses
9.18 Proteintech
9.18.1 Proteintech Details
9.18.2 Proteintech Major Business
9.18.3 Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.18.4 Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Proteintech Recent Developments/Updates
9.18.6 Proteintech Competitive Strengths & Weaknesses
9.19 Cell Signaling Technology
9.19.1 Cell Signaling Technology Details
9.19.2 Cell Signaling Technology Major Business
9.19.3 Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.19.4 Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Cell Signaling Technology Recent Developments/Updates
9.19.6 Cell Signaling Technology Competitive Strengths & Weaknesses
9.20 OriGene
9.20.1 OriGene Details
9.20.2 OriGene Major Business
9.20.3 OriGene Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.20.4 OriGene Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 OriGene Recent Developments/Updates
9.20.6 OriGene Competitive Strengths & Weaknesses
9.21 MyBioSource
9.21.1 MyBioSource Details
9.21.2 MyBioSource Major Business
9.21.3 MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.21.4 MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 MyBioSource Recent Developments/Updates
9.21.6 MyBioSource Competitive Strengths & Weaknesses
9.22 Aviva Systems Biology
9.22.1 Aviva Systems Biology Details
9.22.2 Aviva Systems Biology Major Business
9.22.3 Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.22.4 Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Aviva Systems Biology Recent Developments/Updates
9.22.6 Aviva Systems Biology Competitive Strengths & Weaknesses
9.23 NSJ Bioreagents
9.23.1 NSJ Bioreagents Details
9.23.2 NSJ Bioreagents Major Business
9.23.3 NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.23.4 NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 NSJ Bioreagents Recent Developments/Updates
9.23.6 NSJ Bioreagents Competitive Strengths & Weaknesses
9.24 Boster Bio
9.24.1 Boster Bio Details
9.24.2 Boster Bio Major Business
9.24.3 Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.24.4 Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Boster Bio Recent Developments/Updates
9.24.6 Boster Bio Competitive Strengths & Weaknesses
9.25 KACTUS
9.25.1 KACTUS Details
9.25.2 KACTUS Major Business
9.25.3 KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.25.4 KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 KACTUS Recent Developments/Updates
9.25.6 KACTUS Competitive Strengths & Weaknesses
9.26 ProteoGenix
9.26.1 ProteoGenix Details
9.26.2 ProteoGenix Major Business
9.26.3 ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.26.4 ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 ProteoGenix Recent Developments/Updates
9.26.6 ProteoGenix Competitive Strengths & Weaknesses
9.27 Biorbyt
9.27.1 Biorbyt Details
9.27.2 Biorbyt Major Business
9.27.3 Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.27.4 Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Biorbyt Recent Developments/Updates
9.27.6 Biorbyt Competitive Strengths & Weaknesses
9.28 Abbexa
9.28.1 Abbexa Details
9.28.2 Abbexa Major Business
9.28.3 Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.28.4 Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Abbexa Recent Developments/Updates
9.28.6 Abbexa Competitive Strengths & Weaknesses
9.29 St John?s Laboratory
9.29.1 St John?s Laboratory Details
9.29.2 St John?s Laboratory Major Business
9.29.3 St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.29.4 St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 St John?s Laboratory Recent Developments/Updates
9.29.6 St John?s Laboratory Competitive Strengths & Weaknesses
9.30 Innate Pharma
9.30.1 Innate Pharma Details
9.30.2 Innate Pharma Major Business
9.30.3 Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.30.4 Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Innate Pharma Recent Developments/Updates
9.30.6 Innate Pharma Competitive Strengths & Weaknesses
9.31 ACROBiosystems
9.31.1 ACROBiosystems Details
9.31.2 ACROBiosystems Major Business
9.31.3 ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.31.4 ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 ACROBiosystems Recent Developments/Updates
9.31.6 ACROBiosystems Competitive Strengths & Weaknesses
9.32 Sino Biological
9.32.1 Sino Biological Details
9.32.2 Sino Biological Major Business
9.32.3 Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.32.4 Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 Sino Biological Recent Developments/Updates
9.32.6 Sino Biological Competitive Strengths & Weaknesses
9.33 GenScript
9.33.1 GenScript Details
9.33.2 GenScript Major Business
9.33.3 GenScript Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.33.4 GenScript Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 GenScript Recent Developments/Updates
9.33.6 GenScript Competitive Strengths & Weaknesses
9.34 CUSABIO
9.34.1 CUSABIO Details
9.34.2 CUSABIO Major Business
9.34.3 CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.34.4 CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.34.5 CUSABIO Recent Developments/Updates
9.34.6 CUSABIO Competitive Strengths & Weaknesses
9.35 Solarbio
9.35.1 Solarbio Details
9.35.2 Solarbio Major Business
9.35.3 Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.35.4 Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.35.5 Solarbio Recent Developments/Updates
9.35.6 Solarbio Competitive Strengths & Weaknesses
9.36 WeHelp
9.36.1 WeHelp Details
9.36.2 WeHelp Major Business
9.36.3 WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.36.4 WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.36.5 WeHelp Recent Developments/Updates
9.36.6 WeHelp Competitive Strengths & Weaknesses
9.37 CapitalBio
9.37.1 CapitalBio Details
9.37.2 CapitalBio Major Business
9.37.3 CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.37.4 CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.37.5 CapitalBio Recent Developments/Updates
9.37.6 CapitalBio Competitive Strengths & Weaknesses
9.38 Genomeditech
9.38.1 Genomeditech Details
9.38.2 Genomeditech Major Business
9.38.3 Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.38.4 Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.38.5 Genomeditech Recent Developments/Updates
9.38.6 Genomeditech Competitive Strengths & Weaknesses
9.39 Abnova
9.39.1 Abnova Details
9.39.2 Abnova Major Business
9.39.3 Abnova Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.39.4 Abnova Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.39.5 Abnova Recent Developments/Updates
9.39.6 Abnova Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Killer-cell immunoglobulin-like receptors (KIRs) Industry Chain
10.2 Killer-cell immunoglobulin-like receptors (KIRs) Upstream Analysis
10.3 Killer-cell immunoglobulin-like receptors (KIRs) Midstream Analysis
10.4 Killer-cell immunoglobulin-like receptors (KIRs) Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Killer-cell immunoglobulin-like receptors (KIRs) Introduction
1.2 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Killer-cell immunoglobulin-like receptors (KIRs) Total Market by Region (by Headquarter Location)
1.3.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032)
1.3.3 China Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032)
1.3.4 Europe Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032)
1.3.5 Japan Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032)
1.3.6 South Korea Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032)
1.3.7 ASEAN Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032)
1.3.8 India Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
2.2 World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region
2.2.1 World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2021-2026)
2.2.2 World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Forecast by Region (2027-2032)
2.3 United States Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
2.4 China Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
2.5 Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
2.6 Japan Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
2.7 South Korea Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
2.8 ASEAN Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
2.9 India Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032)
3 WORLD KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS (KIRS) COMPANIES COMPETITIVE ANALYSIS
3.1 World Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Killer-cell immunoglobulin-like receptors (KIRs) in 2025
3.2.3 Global Concentration Ratios (CR8) for Killer-cell immunoglobulin-like receptors (KIRs) in 2025
3.3 Killer-cell immunoglobulin-like receptors (KIRs) Company Evaluation Quadrant
3.4 Killer-cell immunoglobulin-like receptors (KIRs) Market: Overall Company Footprint Analysis
3.4.1 Killer-cell immunoglobulin-like receptors (KIRs) Market: Region Footprint
3.4.2 Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Type Footprint
3.4.3 Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Killer-cell immunoglobulin-like receptors (KIRs) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Killer-cell immunoglobulin-like receptors (KIRs) Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Comparison
4.2.1 United States VS China: Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Killer-cell immunoglobulin-like receptors (KIRs) Companies and Market Share, 2021-2026
4.3.1 United States Based Killer-cell immunoglobulin-like receptors (KIRs) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue, (2021-2026)
4.4 China Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue and Market Share, 2021-2026
4.4.1 China Based Killer-cell immunoglobulin-like receptors (KIRs) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue, (2021-2026)
4.5 Rest of World Based Killer-cell immunoglobulin-like receptors (KIRs) Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Killer-cell immunoglobulin-like receptors (KIRs) Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 KIR Genotyping Products and Services
5.2.2 KIR/CD158 Antibodies and Flow Cytometry Reagents
5.2.3 Recombinant KIR Proteins and Related Research Reagents
5.3 Market Segment by Type
5.3.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026)
5.3.2 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2027-2032)
5.3.3 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TARGET STRUCTURE
6.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Overview by Target Structure: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Target Structure
6.2.1 2D KIR Products
6.2.2 3D KIR Products
6.2.3 Pan-KIR or Mixed KIR Panel Products
6.3 Market Segment by Target Structure
6.3.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure (2021-2026)
6.3.2 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure (2027-2032)
6.3.3 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Target Structure (2027-2032)
7 MARKET ANALYSIS BY FUNCTION
7.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Overview by Function: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Function
7.2.1 Inhibitory KIR-related Products
7.2.2 Activating KIR-related Products
7.2.3 Mixed KIR Panel Products
7.3 Market Segment by Function
7.3.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function (2021-2026)
7.3.2 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function (2027-2032)
7.3.3 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Function (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Medical Science
8.2.2 Experiment
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026)
8.3.2 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2027-2032)
8.3.3 World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Details
9.1.2 Thermo Fisher Scientific Major Business
9.1.3 Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.1.4 Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 Becton Dickinson
9.2.1 Becton Dickinson Details
9.2.2 Becton Dickinson Major Business
9.2.3 Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.2.4 Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Becton Dickinson Recent Developments/Updates
9.2.6 Becton Dickinson Competitive Strengths & Weaknesses
9.3 Beckman Coulter Life Sciences
9.3.1 Beckman Coulter Life Sciences Details
9.3.2 Beckman Coulter Life Sciences Major Business
9.3.3 Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.3.4 Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Beckman Coulter Life Sciences Recent Developments/Updates
9.3.6 Beckman Coulter Life Sciences Competitive Strengths & Weaknesses
9.4 Bio-Rad
9.4.1 Bio-Rad Details
9.4.2 Bio-Rad Major Business
9.4.3 Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.4.4 Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Bio-Rad Recent Developments/Updates
9.4.6 Bio-Rad Competitive Strengths & Weaknesses
9.5 Revvity
9.5.1 Revvity Details
9.5.2 Revvity Major Business
9.5.3 Revvity Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.5.4 Revvity Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Revvity Recent Developments/Updates
9.5.6 Revvity Competitive Strengths & Weaknesses
9.6 Bio-Techne
9.6.1 Bio-Techne Details
9.6.2 Bio-Techne Major Business
9.6.3 Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.6.4 Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Bio-Techne Recent Developments/Updates
9.6.6 Bio-Techne Competitive Strengths & Weaknesses
9.7 Miltenyi Biotec
9.7.1 Miltenyi Biotec Details
9.7.2 Miltenyi Biotec Major Business
9.7.3 Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.7.4 Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Miltenyi Biotec Recent Developments/Updates
9.7.6 Miltenyi Biotec Competitive Strengths & Weaknesses
9.8 Merck
9.8.1 Merck Details
9.8.2 Merck Major Business
9.8.3 Merck Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.8.4 Merck Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Merck Recent Developments/Updates
9.8.6 Merck Competitive Strengths & Weaknesses
9.9 Abcam
9.9.1 Abcam Details
9.9.2 Abcam Major Business
9.9.3 Abcam Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.9.4 Abcam Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Abcam Recent Developments/Updates
9.9.6 Abcam Competitive Strengths & Weaknesses
9.10 Werfen
9.10.1 Werfen Details
9.10.2 Werfen Major Business
9.10.3 Werfen Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.10.4 Werfen Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Werfen Recent Developments/Updates
9.10.6 Werfen Competitive Strengths & Weaknesses
9.11 CareDx
9.11.1 CareDx Details
9.11.2 CareDx Major Business
9.11.3 CareDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.11.4 CareDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 CareDx Recent Developments/Updates
9.11.6 CareDx Competitive Strengths & Weaknesses
9.12 GenDx
9.12.1 GenDx Details
9.12.2 GenDx Major Business
9.12.3 GenDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.12.4 GenDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 GenDx Recent Developments/Updates
9.12.6 GenDx Competitive Strengths & Weaknesses
9.13 HistoGenetics
9.13.1 HistoGenetics Details
9.13.2 HistoGenetics Major Business
9.13.3 HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.13.4 HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 HistoGenetics Recent Developments/Updates
9.13.6 HistoGenetics Competitive Strengths & Weaknesses
9.14 DKMS Life Science Lab
9.14.1 DKMS Life Science Lab Details
9.14.2 DKMS Life Science Lab Major Business
9.14.3 DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.14.4 DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 DKMS Life Science Lab Recent Developments/Updates
9.14.6 DKMS Life Science Lab Competitive Strengths & Weaknesses
9.15 Scisco Genetics
9.15.1 Scisco Genetics Details
9.15.2 Scisco Genetics Major Business
9.15.3 Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.15.4 Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Scisco Genetics Recent Developments/Updates
9.15.6 Scisco Genetics Competitive Strengths & Weaknesses
9.16 Labcorp
9.16.1 Labcorp Details
9.16.2 Labcorp Major Business
9.16.3 Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.16.4 Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Labcorp Recent Developments/Updates
9.16.6 Labcorp Competitive Strengths & Weaknesses
9.17 GeneTex
9.17.1 GeneTex Details
9.17.2 GeneTex Major Business
9.17.3 GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.17.4 GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 GeneTex Recent Developments/Updates
9.17.6 GeneTex Competitive Strengths & Weaknesses
9.18 Proteintech
9.18.1 Proteintech Details
9.18.2 Proteintech Major Business
9.18.3 Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.18.4 Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Proteintech Recent Developments/Updates
9.18.6 Proteintech Competitive Strengths & Weaknesses
9.19 Cell Signaling Technology
9.19.1 Cell Signaling Technology Details
9.19.2 Cell Signaling Technology Major Business
9.19.3 Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.19.4 Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Cell Signaling Technology Recent Developments/Updates
9.19.6 Cell Signaling Technology Competitive Strengths & Weaknesses
9.20 OriGene
9.20.1 OriGene Details
9.20.2 OriGene Major Business
9.20.3 OriGene Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.20.4 OriGene Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 OriGene Recent Developments/Updates
9.20.6 OriGene Competitive Strengths & Weaknesses
9.21 MyBioSource
9.21.1 MyBioSource Details
9.21.2 MyBioSource Major Business
9.21.3 MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.21.4 MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 MyBioSource Recent Developments/Updates
9.21.6 MyBioSource Competitive Strengths & Weaknesses
9.22 Aviva Systems Biology
9.22.1 Aviva Systems Biology Details
9.22.2 Aviva Systems Biology Major Business
9.22.3 Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.22.4 Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Aviva Systems Biology Recent Developments/Updates
9.22.6 Aviva Systems Biology Competitive Strengths & Weaknesses
9.23 NSJ Bioreagents
9.23.1 NSJ Bioreagents Details
9.23.2 NSJ Bioreagents Major Business
9.23.3 NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.23.4 NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 NSJ Bioreagents Recent Developments/Updates
9.23.6 NSJ Bioreagents Competitive Strengths & Weaknesses
9.24 Boster Bio
9.24.1 Boster Bio Details
9.24.2 Boster Bio Major Business
9.24.3 Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.24.4 Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Boster Bio Recent Developments/Updates
9.24.6 Boster Bio Competitive Strengths & Weaknesses
9.25 KACTUS
9.25.1 KACTUS Details
9.25.2 KACTUS Major Business
9.25.3 KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.25.4 KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 KACTUS Recent Developments/Updates
9.25.6 KACTUS Competitive Strengths & Weaknesses
9.26 ProteoGenix
9.26.1 ProteoGenix Details
9.26.2 ProteoGenix Major Business
9.26.3 ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.26.4 ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 ProteoGenix Recent Developments/Updates
9.26.6 ProteoGenix Competitive Strengths & Weaknesses
9.27 Biorbyt
9.27.1 Biorbyt Details
9.27.2 Biorbyt Major Business
9.27.3 Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.27.4 Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Biorbyt Recent Developments/Updates
9.27.6 Biorbyt Competitive Strengths & Weaknesses
9.28 Abbexa
9.28.1 Abbexa Details
9.28.2 Abbexa Major Business
9.28.3 Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.28.4 Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Abbexa Recent Developments/Updates
9.28.6 Abbexa Competitive Strengths & Weaknesses
9.29 St John?s Laboratory
9.29.1 St John?s Laboratory Details
9.29.2 St John?s Laboratory Major Business
9.29.3 St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.29.4 St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 St John?s Laboratory Recent Developments/Updates
9.29.6 St John?s Laboratory Competitive Strengths & Weaknesses
9.30 Innate Pharma
9.30.1 Innate Pharma Details
9.30.2 Innate Pharma Major Business
9.30.3 Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.30.4 Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Innate Pharma Recent Developments/Updates
9.30.6 Innate Pharma Competitive Strengths & Weaknesses
9.31 ACROBiosystems
9.31.1 ACROBiosystems Details
9.31.2 ACROBiosystems Major Business
9.31.3 ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.31.4 ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 ACROBiosystems Recent Developments/Updates
9.31.6 ACROBiosystems Competitive Strengths & Weaknesses
9.32 Sino Biological
9.32.1 Sino Biological Details
9.32.2 Sino Biological Major Business
9.32.3 Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.32.4 Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 Sino Biological Recent Developments/Updates
9.32.6 Sino Biological Competitive Strengths & Weaknesses
9.33 GenScript
9.33.1 GenScript Details
9.33.2 GenScript Major Business
9.33.3 GenScript Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.33.4 GenScript Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 GenScript Recent Developments/Updates
9.33.6 GenScript Competitive Strengths & Weaknesses
9.34 CUSABIO
9.34.1 CUSABIO Details
9.34.2 CUSABIO Major Business
9.34.3 CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.34.4 CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.34.5 CUSABIO Recent Developments/Updates
9.34.6 CUSABIO Competitive Strengths & Weaknesses
9.35 Solarbio
9.35.1 Solarbio Details
9.35.2 Solarbio Major Business
9.35.3 Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.35.4 Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.35.5 Solarbio Recent Developments/Updates
9.35.6 Solarbio Competitive Strengths & Weaknesses
9.36 WeHelp
9.36.1 WeHelp Details
9.36.2 WeHelp Major Business
9.36.3 WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.36.4 WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.36.5 WeHelp Recent Developments/Updates
9.36.6 WeHelp Competitive Strengths & Weaknesses
9.37 CapitalBio
9.37.1 CapitalBio Details
9.37.2 CapitalBio Major Business
9.37.3 CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.37.4 CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.37.5 CapitalBio Recent Developments/Updates
9.37.6 CapitalBio Competitive Strengths & Weaknesses
9.38 Genomeditech
9.38.1 Genomeditech Details
9.38.2 Genomeditech Major Business
9.38.3 Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.38.4 Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.38.5 Genomeditech Recent Developments/Updates
9.38.6 Genomeditech Competitive Strengths & Weaknesses
9.39 Abnova
9.39.1 Abnova Details
9.39.2 Abnova Major Business
9.39.3 Abnova Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
9.39.4 Abnova Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
9.39.5 Abnova Recent Developments/Updates
9.39.6 Abnova Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Killer-cell immunoglobulin-like receptors (KIRs) Industry Chain
10.2 Killer-cell immunoglobulin-like receptors (KIRs) Upstream Analysis
10.3 Killer-cell immunoglobulin-like receptors (KIRs) Midstream Analysis
10.4 Killer-cell immunoglobulin-like receptors (KIRs) Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Killer-cell immunoglobulin-like receptors (KIRs) Players in 2025
Table 12. World Killer-cell immunoglobulin-like receptors (KIRs) Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Killer-cell immunoglobulin-like receptors (KIRs) Company Evaluation Quadrant
Table 14. Head Office of Key Killer-cell immunoglobulin-like receptors (KIRs) Players
Table 15. Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Type Footprint
Table 16. Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Application Footprint
Table 17. Killer-cell immunoglobulin-like receptors (KIRs) Mergers & Acquisitions Activity
Table 18. United States VS China Killer-cell immunoglobulin-like receptors (KIRs) Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Killer-cell immunoglobulin-like receptors (KIRs) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share (2021-2026)
Table 23. China Based Killer-cell immunoglobulin-like receptors (KIRs) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share (2021-2026)
Table 26. Rest of World Based Killer-cell immunoglobulin-like receptors (KIRs) Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share (2021-2026)
Table 29. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2027-2032) & (USD Million)
Table 32. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure, (USD Million), 2021 & 2025 & 2032
Table 33. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Value by Target Structure (2021-2026) & (USD Million)
Table 34. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure (2027-2032) & (USD Million)
Table 35. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function, (USD Million), 2021 & 2025 & 2032
Table 36. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Value by Function (2021-2026) & (USD Million)
Table 37. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function (2027-2032) & (USD Million)
Table 38. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026) & (USD Million)
Table 40. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 44. Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Becton Dickinson Basic Information, Manufacturing Base and Competitors
Table 48. Becton Dickinson Major Business
Table 49. Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 50. Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Becton Dickinson Recent Developments/Updates
Table 52. Becton Dickinson Competitive Strengths & Weaknesses
Table 53. Beckman Coulter Life Sciences Basic Information, Manufacturing Base and Competitors
Table 54. Beckman Coulter Life Sciences Major Business
Table 55. Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 56. Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Beckman Coulter Life Sciences Recent Developments/Updates
Table 58. Beckman Coulter Life Sciences Competitive Strengths & Weaknesses
Table 59. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 60. Bio-Rad Major Business
Table 61. Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 62. Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Bio-Rad Recent Developments/Updates
Table 64. Bio-Rad Competitive Strengths & Weaknesses
Table 65. Revvity Basic Information, Manufacturing Base and Competitors
Table 66. Revvity Major Business
Table 67. Revvity Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 68. Revvity Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Revvity Recent Developments/Updates
Table 70. Revvity Competitive Strengths & Weaknesses
Table 71. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 72. Bio-Techne Major Business
Table 73. Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 74. Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Bio-Techne Recent Developments/Updates
Table 76. Bio-Techne Competitive Strengths & Weaknesses
Table 77. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 78. Miltenyi Biotec Major Business
Table 79. Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 80. Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Miltenyi Biotec Recent Developments/Updates
Table 82. Miltenyi Biotec Competitive Strengths & Weaknesses
Table 83. Merck Basic Information, Manufacturing Base and Competitors
Table 84. Merck Major Business
Table 85. Merck Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 86. Merck Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Merck Recent Developments/Updates
Table 88. Merck Competitive Strengths & Weaknesses
Table 89. Abcam Basic Information, Manufacturing Base and Competitors
Table 90. Abcam Major Business
Table 91. Abcam Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 92. Abcam Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Abcam Recent Developments/Updates
Table 94. Abcam Competitive Strengths & Weaknesses
Table 95. Werfen Basic Information, Manufacturing Base and Competitors
Table 96. Werfen Major Business
Table 97. Werfen Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 98. Werfen Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Werfen Recent Developments/Updates
Table 100. Werfen Competitive Strengths & Weaknesses
Table 101. CareDx Basic Information, Manufacturing Base and Competitors
Table 102. CareDx Major Business
Table 103. CareDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 104. CareDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. CareDx Recent Developments/Updates
Table 106. CareDx Competitive Strengths & Weaknesses
Table 107. GenDx Basic Information, Manufacturing Base and Competitors
Table 108. GenDx Major Business
Table 109. GenDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 110. GenDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. GenDx Recent Developments/Updates
Table 112. GenDx Competitive Strengths & Weaknesses
Table 113. HistoGenetics Basic Information, Manufacturing Base and Competitors
Table 114. HistoGenetics Major Business
Table 115. HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 116. HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. HistoGenetics Recent Developments/Updates
Table 118. HistoGenetics Competitive Strengths & Weaknesses
Table 119. DKMS Life Science Lab Basic Information, Manufacturing Base and Competitors
Table 120. DKMS Life Science Lab Major Business
Table 121. DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 122. DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. DKMS Life Science Lab Recent Developments/Updates
Table 124. DKMS Life Science Lab Competitive Strengths & Weaknesses
Table 125. Scisco Genetics Basic Information, Manufacturing Base and Competitors
Table 126. Scisco Genetics Major Business
Table 127. Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 128. Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Scisco Genetics Recent Developments/Updates
Table 130. Scisco Genetics Competitive Strengths & Weaknesses
Table 131. Labcorp Basic Information, Manufacturing Base and Competitors
Table 132. Labcorp Major Business
Table 133. Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 134. Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Labcorp Recent Developments/Updates
Table 136. Labcorp Competitive Strengths & Weaknesses
Table 137. GeneTex Basic Information, Manufacturing Base and Competitors
Table 138. GeneTex Major Business
Table 139. GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 140. GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. GeneTex Recent Developments/Updates
Table 142. GeneTex Competitive Strengths & Weaknesses
Table 143. Proteintech Basic Information, Manufacturing Base and Competitors
Table 144. Proteintech Major Business
Table 145. Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 146. Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Proteintech Recent Developments/Updates
Table 148. Proteintech Competitive Strengths & Weaknesses
Table 149. Cell Signaling Technology Basic Information, Manufacturing Base and Competitors
Table 150. Cell Signaling Technology Major Business
Table 151. Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 152. Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Cell Signaling Technology Recent Developments/Updates
Table 154. Cell Signaling Technology Competitive Strengths & Weaknesses
Table 155. OriGene Basic Information, Manufacturing Base and Competitors
Table 156. OriGene Major Business
Table 157. OriGene Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 158. OriGene Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. OriGene Recent Developments/Updates
Table 160. OriGene Competitive Strengths & Weaknesses
Table 161. MyBioSource Basic Information, Manufacturing Base and Competitors
Table 162. MyBioSource Major Business
Table 163. MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 164. MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. MyBioSource Recent Developments/Updates
Table 166. MyBioSource Competitive Strengths & Weaknesses
Table 167. Aviva Systems Biology Basic Information, Manufacturing Base and Competitors
Table 168. Aviva Systems Biology Major Business
Table 169. Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 170. Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Aviva Systems Biology Recent Developments/Updates
Table 172. Aviva Systems Biology Competitive Strengths & Weaknesses
Table 173. NSJ Bioreagents Basic Information, Manufacturing Base and Competitors
Table 174. NSJ Bioreagents Major Business
Table 175. NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 176. NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. NSJ Bioreagents Recent Developments/Updates
Table 178. NSJ Bioreagents Competitive Strengths & Weaknesses
Table 179. Boster Bio Basic Information, Manufacturing Base and Competitors
Table 180. Boster Bio Major Business
Table 181. Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 182. Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Boster Bio Recent Developments/Updates
Table 184. Boster Bio Competitive Strengths & Weaknesses
Table 185. KACTUS Basic Information, Manufacturing Base and Competitors
Table 186. KACTUS Major Business
Table 187. KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 188. KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. KACTUS Recent Developments/Updates
Table 190. KACTUS Competitive Strengths & Weaknesses
Table 191. ProteoGenix Basic Information, Manufacturing Base and Competitors
Table 192. ProteoGenix Major Business
Table 193. ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 194. ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. ProteoGenix Recent Developments/Updates
Table 196. ProteoGenix Competitive Strengths & Weaknesses
Table 197. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 198. Biorbyt Major Business
Table 199. Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 200. Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Biorbyt Recent Developments/Updates
Table 202. Biorbyt Competitive Strengths & Weaknesses
Table 203. Abbexa Basic Information, Manufacturing Base and Competitors
Table 204. Abbexa Major Business
Table 205. Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 206. Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Abbexa Recent Developments/Updates
Table 208. Abbexa Competitive Strengths & Weaknesses
Table 209. St John?s Laboratory Basic Information, Manufacturing Base and Competitors
Table 210. St John?s Laboratory Major Business
Table 211. St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 212. St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. St John?s Laboratory Recent Developments/Updates
Table 214. St John?s Laboratory Competitive Strengths & Weaknesses
Table 215. Innate Pharma Basic Information, Manufacturing Base and Competitors
Table 216. Innate Pharma Major Business
Table 217. Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 218. Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Innate Pharma Recent Developments/Updates
Table 220. Innate Pharma Competitive Strengths & Weaknesses
Table 221. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 222. ACROBiosystems Major Business
Table 223. ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 224. ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. ACROBiosystems Recent Developments/Updates
Table 226. ACROBiosystems Competitive Strengths & Weaknesses
Table 227. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 228. Sino Biological Major Business
Table 229. Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 230. Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. Sino Biological Recent Developments/Updates
Table 232. Sino Biological Competitive Strengths & Weaknesses
Table 233. GenScript Basic Information, Manufacturing Base and Competitors
Table 234. GenScript Major Business
Table 235. GenScript Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 236. GenScript Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. GenScript Recent Developments/Updates
Table 238. GenScript Competitive Strengths & Weaknesses
Table 239. CUSABIO Basic Information, Manufacturing Base and Competitors
Table 240. CUSABIO Major Business
Table 241. CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 242. CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 243. CUSABIO Recent Developments/Updates
Table 244. CUSABIO Competitive Strengths & Weaknesses
Table 245. Solarbio Basic Information, Manufacturing Base and Competitors
Table 246. Solarbio Major Business
Table 247. Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 248. Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 249. Solarbio Recent Developments/Updates
Table 250. Solarbio Competitive Strengths & Weaknesses
Table 251. WeHelp Basic Information, Manufacturing Base and Competitors
Table 252. WeHelp Major Business
Table 253. WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 254. WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 255. WeHelp Recent Developments/Updates
Table 256. WeHelp Competitive Strengths & Weaknesses
Table 257. CapitalBio Basic Information, Manufacturing Base and Competitors
Table 258. CapitalBio Major Business
Table 259. CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 260. CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 261. CapitalBio Recent Developments/Updates
Table 262. CapitalBio Competitive Strengths & Weaknesses
Table 263. Genomeditech Basic Information, Manufacturing Base and Competitors
Table 264. Genomeditech Major Business
Table 265. Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 266. Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 267. Genomeditech Recent Developments/Updates
Table 268. Genomeditech Competitive Strengths & Weaknesses
Table 269. Abnova Basic Information, Manufacturing Base and Competitors
Table 270. Abnova Major Business
Table 271. Abnova Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 272. Abnova Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 273. Abnova Recent Developments/Updates
Table 274. Abnova Competitive Strengths & Weaknesses
Table 275. Global Key Players of Killer-cell immunoglobulin-like receptors (KIRs) Upstream (Raw Materials)
Table 276. Global Killer-cell immunoglobulin-like receptors (KIRs) Typical Customers
Table 1. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Killer-cell immunoglobulin-like receptors (KIRs) Players in 2025
Table 12. World Killer-cell immunoglobulin-like receptors (KIRs) Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Killer-cell immunoglobulin-like receptors (KIRs) Company Evaluation Quadrant
Table 14. Head Office of Key Killer-cell immunoglobulin-like receptors (KIRs) Players
Table 15. Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Type Footprint
Table 16. Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Application Footprint
Table 17. Killer-cell immunoglobulin-like receptors (KIRs) Mergers & Acquisitions Activity
Table 18. United States VS China Killer-cell immunoglobulin-like receptors (KIRs) Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Killer-cell immunoglobulin-like receptors (KIRs) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share (2021-2026)
Table 23. China Based Killer-cell immunoglobulin-like receptors (KIRs) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share (2021-2026)
Table 26. Rest of World Based Killer-cell immunoglobulin-like receptors (KIRs) Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share (2021-2026)
Table 29. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2027-2032) & (USD Million)
Table 32. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure, (USD Million), 2021 & 2025 & 2032
Table 33. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Value by Target Structure (2021-2026) & (USD Million)
Table 34. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure (2027-2032) & (USD Million)
Table 35. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function, (USD Million), 2021 & 2025 & 2032
Table 36. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Value by Function (2021-2026) & (USD Million)
Table 37. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function (2027-2032) & (USD Million)
Table 38. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026) & (USD Million)
Table 40. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 44. Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Becton Dickinson Basic Information, Manufacturing Base and Competitors
Table 48. Becton Dickinson Major Business
Table 49. Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 50. Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Becton Dickinson Recent Developments/Updates
Table 52. Becton Dickinson Competitive Strengths & Weaknesses
Table 53. Beckman Coulter Life Sciences Basic Information, Manufacturing Base and Competitors
Table 54. Beckman Coulter Life Sciences Major Business
Table 55. Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 56. Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Beckman Coulter Life Sciences Recent Developments/Updates
Table 58. Beckman Coulter Life Sciences Competitive Strengths & Weaknesses
Table 59. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 60. Bio-Rad Major Business
Table 61. Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 62. Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Bio-Rad Recent Developments/Updates
Table 64. Bio-Rad Competitive Strengths & Weaknesses
Table 65. Revvity Basic Information, Manufacturing Base and Competitors
Table 66. Revvity Major Business
Table 67. Revvity Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 68. Revvity Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Revvity Recent Developments/Updates
Table 70. Revvity Competitive Strengths & Weaknesses
Table 71. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 72. Bio-Techne Major Business
Table 73. Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 74. Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Bio-Techne Recent Developments/Updates
Table 76. Bio-Techne Competitive Strengths & Weaknesses
Table 77. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 78. Miltenyi Biotec Major Business
Table 79. Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 80. Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Miltenyi Biotec Recent Developments/Updates
Table 82. Miltenyi Biotec Competitive Strengths & Weaknesses
Table 83. Merck Basic Information, Manufacturing Base and Competitors
Table 84. Merck Major Business
Table 85. Merck Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 86. Merck Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Merck Recent Developments/Updates
Table 88. Merck Competitive Strengths & Weaknesses
Table 89. Abcam Basic Information, Manufacturing Base and Competitors
Table 90. Abcam Major Business
Table 91. Abcam Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 92. Abcam Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Abcam Recent Developments/Updates
Table 94. Abcam Competitive Strengths & Weaknesses
Table 95. Werfen Basic Information, Manufacturing Base and Competitors
Table 96. Werfen Major Business
Table 97. Werfen Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 98. Werfen Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Werfen Recent Developments/Updates
Table 100. Werfen Competitive Strengths & Weaknesses
Table 101. CareDx Basic Information, Manufacturing Base and Competitors
Table 102. CareDx Major Business
Table 103. CareDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 104. CareDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. CareDx Recent Developments/Updates
Table 106. CareDx Competitive Strengths & Weaknesses
Table 107. GenDx Basic Information, Manufacturing Base and Competitors
Table 108. GenDx Major Business
Table 109. GenDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 110. GenDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. GenDx Recent Developments/Updates
Table 112. GenDx Competitive Strengths & Weaknesses
Table 113. HistoGenetics Basic Information, Manufacturing Base and Competitors
Table 114. HistoGenetics Major Business
Table 115. HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 116. HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. HistoGenetics Recent Developments/Updates
Table 118. HistoGenetics Competitive Strengths & Weaknesses
Table 119. DKMS Life Science Lab Basic Information, Manufacturing Base and Competitors
Table 120. DKMS Life Science Lab Major Business
Table 121. DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 122. DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. DKMS Life Science Lab Recent Developments/Updates
Table 124. DKMS Life Science Lab Competitive Strengths & Weaknesses
Table 125. Scisco Genetics Basic Information, Manufacturing Base and Competitors
Table 126. Scisco Genetics Major Business
Table 127. Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 128. Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Scisco Genetics Recent Developments/Updates
Table 130. Scisco Genetics Competitive Strengths & Weaknesses
Table 131. Labcorp Basic Information, Manufacturing Base and Competitors
Table 132. Labcorp Major Business
Table 133. Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 134. Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Labcorp Recent Developments/Updates
Table 136. Labcorp Competitive Strengths & Weaknesses
Table 137. GeneTex Basic Information, Manufacturing Base and Competitors
Table 138. GeneTex Major Business
Table 139. GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 140. GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. GeneTex Recent Developments/Updates
Table 142. GeneTex Competitive Strengths & Weaknesses
Table 143. Proteintech Basic Information, Manufacturing Base and Competitors
Table 144. Proteintech Major Business
Table 145. Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 146. Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Proteintech Recent Developments/Updates
Table 148. Proteintech Competitive Strengths & Weaknesses
Table 149. Cell Signaling Technology Basic Information, Manufacturing Base and Competitors
Table 150. Cell Signaling Technology Major Business
Table 151. Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 152. Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Cell Signaling Technology Recent Developments/Updates
Table 154. Cell Signaling Technology Competitive Strengths & Weaknesses
Table 155. OriGene Basic Information, Manufacturing Base and Competitors
Table 156. OriGene Major Business
Table 157. OriGene Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 158. OriGene Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. OriGene Recent Developments/Updates
Table 160. OriGene Competitive Strengths & Weaknesses
Table 161. MyBioSource Basic Information, Manufacturing Base and Competitors
Table 162. MyBioSource Major Business
Table 163. MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 164. MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. MyBioSource Recent Developments/Updates
Table 166. MyBioSource Competitive Strengths & Weaknesses
Table 167. Aviva Systems Biology Basic Information, Manufacturing Base and Competitors
Table 168. Aviva Systems Biology Major Business
Table 169. Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 170. Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Aviva Systems Biology Recent Developments/Updates
Table 172. Aviva Systems Biology Competitive Strengths & Weaknesses
Table 173. NSJ Bioreagents Basic Information, Manufacturing Base and Competitors
Table 174. NSJ Bioreagents Major Business
Table 175. NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 176. NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. NSJ Bioreagents Recent Developments/Updates
Table 178. NSJ Bioreagents Competitive Strengths & Weaknesses
Table 179. Boster Bio Basic Information, Manufacturing Base and Competitors
Table 180. Boster Bio Major Business
Table 181. Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 182. Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Boster Bio Recent Developments/Updates
Table 184. Boster Bio Competitive Strengths & Weaknesses
Table 185. KACTUS Basic Information, Manufacturing Base and Competitors
Table 186. KACTUS Major Business
Table 187. KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 188. KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. KACTUS Recent Developments/Updates
Table 190. KACTUS Competitive Strengths & Weaknesses
Table 191. ProteoGenix Basic Information, Manufacturing Base and Competitors
Table 192. ProteoGenix Major Business
Table 193. ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 194. ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. ProteoGenix Recent Developments/Updates
Table 196. ProteoGenix Competitive Strengths & Weaknesses
Table 197. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 198. Biorbyt Major Business
Table 199. Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 200. Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Biorbyt Recent Developments/Updates
Table 202. Biorbyt Competitive Strengths & Weaknesses
Table 203. Abbexa Basic Information, Manufacturing Base and Competitors
Table 204. Abbexa Major Business
Table 205. Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 206. Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Abbexa Recent Developments/Updates
Table 208. Abbexa Competitive Strengths & Weaknesses
Table 209. St John?s Laboratory Basic Information, Manufacturing Base and Competitors
Table 210. St John?s Laboratory Major Business
Table 211. St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 212. St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. St John?s Laboratory Recent Developments/Updates
Table 214. St John?s Laboratory Competitive Strengths & Weaknesses
Table 215. Innate Pharma Basic Information, Manufacturing Base and Competitors
Table 216. Innate Pharma Major Business
Table 217. Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 218. Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Innate Pharma Recent Developments/Updates
Table 220. Innate Pharma Competitive Strengths & Weaknesses
Table 221. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 222. ACROBiosystems Major Business
Table 223. ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 224. ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. ACROBiosystems Recent Developments/Updates
Table 226. ACROBiosystems Competitive Strengths & Weaknesses
Table 227. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 228. Sino Biological Major Business
Table 229. Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 230. Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. Sino Biological Recent Developments/Updates
Table 232. Sino Biological Competitive Strengths & Weaknesses
Table 233. GenScript Basic Information, Manufacturing Base and Competitors
Table 234. GenScript Major Business
Table 235. GenScript Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 236. GenScript Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. GenScript Recent Developments/Updates
Table 238. GenScript Competitive Strengths & Weaknesses
Table 239. CUSABIO Basic Information, Manufacturing Base and Competitors
Table 240. CUSABIO Major Business
Table 241. CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 242. CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 243. CUSABIO Recent Developments/Updates
Table 244. CUSABIO Competitive Strengths & Weaknesses
Table 245. Solarbio Basic Information, Manufacturing Base and Competitors
Table 246. Solarbio Major Business
Table 247. Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 248. Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 249. Solarbio Recent Developments/Updates
Table 250. Solarbio Competitive Strengths & Weaknesses
Table 251. WeHelp Basic Information, Manufacturing Base and Competitors
Table 252. WeHelp Major Business
Table 253. WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 254. WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 255. WeHelp Recent Developments/Updates
Table 256. WeHelp Competitive Strengths & Weaknesses
Table 257. CapitalBio Basic Information, Manufacturing Base and Competitors
Table 258. CapitalBio Major Business
Table 259. CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 260. CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 261. CapitalBio Recent Developments/Updates
Table 262. CapitalBio Competitive Strengths & Weaknesses
Table 263. Genomeditech Basic Information, Manufacturing Base and Competitors
Table 264. Genomeditech Major Business
Table 265. Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 266. Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 267. Genomeditech Recent Developments/Updates
Table 268. Genomeditech Competitive Strengths & Weaknesses
Table 269. Abnova Basic Information, Manufacturing Base and Competitors
Table 270. Abnova Major Business
Table 271. Abnova Killer-cell immunoglobulin-like receptors (KIRs) Product and Services
Table 272. Abnova Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 273. Abnova Recent Developments/Updates
Table 274. Abnova Competitive Strengths & Weaknesses
Table 275. Global Key Players of Killer-cell immunoglobulin-like receptors (KIRs) Upstream (Raw Materials)
Table 276. Global Killer-cell immunoglobulin-like receptors (KIRs) Typical Customers
LIST OF FIGURES
Figure 1. Killer-cell immunoglobulin-like receptors (KIRs) Picture
Figure 2. World Killer-cell immunoglobulin-like receptors (KIRs) Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Killer-cell immunoglobulin-like receptors (KIRs) Total Revenue (2021-2032) & (USD Million)
Figure 4. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032) & (USD Million)
Figure 13. Killer-cell immunoglobulin-like receptors (KIRs) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 16. World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 18. China Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 23. India Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Killer-cell immunoglobulin-like receptors (KIRs) by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Killer-cell immunoglobulin-like receptors (KIRs) Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Killer-cell immunoglobulin-like receptors (KIRs) Markets in 2025
Figure 27. United States VS China: Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type in 2025
Figure 31. KIR Genotyping Products and Services
Figure 32. KIR/CD158 Antibodies and Flow Cytometry Reagents
Figure 33. Recombinant KIR Proteins and Related Research Reagents
Figure 34. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2021-2032)
Figure 35. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure, (USD Million), 2021 & 2025 & 2032
Figure 36. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Target Structure in 2025
Figure 37. 2D KIR Products
Figure 38. 3D KIR Products
Figure 39. Pan-KIR or Mixed KIR Panel Products
Figure 40. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Target Structure (2021-2032)
Figure 41. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function, (USD Million), 2021 & 2025 & 2032
Figure 42. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Function in 2025
Figure 43. Inhibitory KIR-related Products
Figure 44. Activating KIR-related Products
Figure 45. Mixed KIR Panel Products
Figure 46. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Function (2021-2032)
Figure 47. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application in 2025
Figure 49. Medical Science
Figure 50. Experiment
Figure 51. Other
Figure 52. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2032)
Figure 53. Killer-cell immunoglobulin-like receptors (KIRs) Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Killer-cell immunoglobulin-like receptors (KIRs) Picture
Figure 2. World Killer-cell immunoglobulin-like receptors (KIRs) Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Killer-cell immunoglobulin-like receptors (KIRs) Total Revenue (2021-2032) & (USD Million)
Figure 4. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Killer-cell immunoglobulin-like receptors (KIRs) Revenue (2021-2032) & (USD Million)
Figure 13. Killer-cell immunoglobulin-like receptors (KIRs) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 16. World Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 18. China Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 23. India Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Killer-cell immunoglobulin-like receptors (KIRs) by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Killer-cell immunoglobulin-like receptors (KIRs) Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Killer-cell immunoglobulin-like receptors (KIRs) Markets in 2025
Figure 27. United States VS China: Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type in 2025
Figure 31. KIR Genotyping Products and Services
Figure 32. KIR/CD158 Antibodies and Flow Cytometry Reagents
Figure 33. Recombinant KIR Proteins and Related Research Reagents
Figure 34. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2021-2032)
Figure 35. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure, (USD Million), 2021 & 2025 & 2032
Figure 36. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Target Structure in 2025
Figure 37. 2D KIR Products
Figure 38. 3D KIR Products
Figure 39. Pan-KIR or Mixed KIR Panel Products
Figure 40. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Target Structure (2021-2032)
Figure 41. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function, (USD Million), 2021 & 2025 & 2032
Figure 42. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Function in 2025
Figure 43. Inhibitory KIR-related Products
Figure 44. Activating KIR-related Products
Figure 45. Mixed KIR Panel Products
Figure 46. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Function (2021-2032)
Figure 47. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application in 2025
Figure 49. Medical Science
Figure 50. Experiment
Figure 51. Other
Figure 52. World Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2032)
Figure 53. Killer-cell immunoglobulin-like receptors (KIRs) Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
